{"parse":{"title":"Tardive dyskinesia","pageid":321556,"revid":859534941,"text":{"*":"<div class=\"mw-parser-output\"><div role=\"note\" class=\"hatnote navigation-not-searchable\">Not to be confused with <a href=\"/wiki/Dyskinetic_cerebral_palsy\" class=\"mw-redirect\" title=\"Dyskinetic cerebral palsy\">dyskinetic cerebral palsy</a>.</div>\n<table class=\"infobox\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold;background:#ccc\">Tardive dyskinesia</th></tr><tr><th scope=\"row\">Synonyms</th><td>\nLinguofacial dyskinesia, tardive dystonia, tardive oral dyskinesia<sup id=\"cite_ref-GARD2017_1-0\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup></td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<a href=\"/wiki/File:Dopamine-3d-CPK.png\" class=\"image\"><img alt=\"Dopamine-3d-CPK.png\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Dopamine-3d-CPK.png/300px-Dopamine-3d-CPK.png\" width=\"300\" height=\"206\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Dopamine-3d-CPK.png/450px-Dopamine-3d-CPK.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Dopamine-3d-CPK.png/600px-Dopamine-3d-CPK.png 2x\" data-file-width=\"916\" data-file-height=\"628\" /></a></td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\nTardive dyskinesia is believed to involve the neurotransmitter <a href=\"/wiki/Dopamine\" title=\"Dopamine\">dopamine</a>.</td></tr><tr><th scope=\"row\">Pronunciation</th><td>\n<div class=\"plainlist\"><ul><li><span class=\"nowrap\"><span class=\"IPA nopopups noexcerpt\"><a href=\"/wiki/Help:IPA/English\" title=\"Help:IPA/English\">/<span style=\"border-bottom:1px dotted\"><span title=\"/\u02c8/: primary stress follows\">\u02c8</span><span title=\"&#39;t&#39; in &#39;tie&#39;\">t</span><span title=\"/\u0251\u02d0r/: &#39;ar&#39; in &#39;far&#39;\">\u0251\u02d0r</span><span title=\"&#39;d&#39; in &#39;dye&#39;\">d</span><span title=\"/\u026a/: &#39;i&#39; in &#39;kit&#39;\">\u026a</span><span title=\"&#39;v&#39; in &#39;vie&#39;\">v</span></span> <wbr /><span style=\"border-bottom:1px dotted\"><span title=\"/\u02cc/: secondary stress follows\">\u02cc</span><span title=\"&#39;d&#39; in &#39;dye&#39;\">d</span><span title=\"/\u026a/: &#39;i&#39; in &#39;kit&#39;\">\u026a</span><span title=\"&#39;s&#39; in &#39;sigh&#39;\">s</span><span title=\"&#39;k&#39; in &#39;kind&#39;\">k</span><span title=\"/\u026a/: &#39;i&#39; in &#39;kit&#39;\">\u026a</span><span title=\"/\u02c8/: primary stress follows\">\u02c8</span><span title=\"&#39;n&#39; in &#39;nigh&#39;\">n</span><span title=\"/i\u02d0/: &#39;ee&#39; in &#39;fleece&#39;\">i\u02d0</span><span title=\"/\u0292/: &#39;s&#39; in &#39;pleasure&#39;\">\u0292</span><span title=\"/\u0259/: &#39;a&#39; in &#39;about&#39;\">\u0259</span></span>/</a></span></span>&#x20;</li></ul></div></td></tr><tr><th scope=\"row\"><a href=\"/wiki/Specialty_(medicine)\" title=\"Specialty (medicine)\">Specialty</a></th><td>\n<a href=\"/wiki/Neurology\" title=\"Neurology\">Neurology</a>, <a href=\"/wiki/Psychiatry\" title=\"Psychiatry\">psychiatry</a></td></tr><tr><th scope=\"row\">Symptoms</th><td>\nInvoluntary, repetitive body movements<sup id=\"cite_ref-GARD2017_1-1\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup></td></tr><tr><th scope=\"row\">Causes</th><td>\n<a href=\"/wiki/Neuroleptic_medication\" class=\"mw-redirect\" title=\"Neuroleptic medication\">Neuroleptic medications</a> (antipsychotics, <a href=\"/wiki/Metoclopramide\" title=\"Metoclopramide\">metoclopramide</a>)<sup id=\"cite_ref-GARD2017_1-2\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-NORD2015_2-0\" class=\"reference\"><a href=\"#cite_note-NORD2015-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\"><a href=\"/wiki/Diagnostic_method\" class=\"mw-redirect\" title=\"Diagnostic method\">Diagnostic method</a></th><td>\nBased on symptoms after ruling out other potential causes<sup id=\"cite_ref-GARD2017_1-3\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup></td></tr><tr><th scope=\"row\"><a href=\"/wiki/Differential_diagnosis\" title=\"Differential diagnosis\">Differential diagnosis</a></th><td>\n<a href=\"/wiki/Huntington%27s_disease\" title=\"Huntington&#39;s disease\">Huntington's disease</a>, <a href=\"/wiki/Cerebral_palsy\" title=\"Cerebral palsy\">cerebral palsy</a>, <a href=\"/wiki/Tourette_syndrome\" title=\"Tourette syndrome\">Tourette syndrome</a>, <a href=\"/wiki/Dystonia\" title=\"Dystonia\">dystonia</a><sup id=\"cite_ref-NORD2015_2-1\" class=\"reference\"><a href=\"#cite_note-NORD2015-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\">Prevention</th><td>\nUsing lowest possible dose of neuroleptic medication<sup id=\"cite_ref-Vi2016_3-0\" class=\"reference\"><a href=\"#cite_note-Vi2016-3\">&#91;3&#93;</a></sup></td></tr><tr><th scope=\"row\">Treatment</th><td>\nStopping neuroleptic medication if possible, switching to <a href=\"/wiki/Clozapine\" title=\"Clozapine\">clozapine</a><sup id=\"cite_ref-GARD2017_1-4\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup></td></tr><tr><th scope=\"row\">Medication</th><td>\n<a href=\"/wiki/Valbenazine\" title=\"Valbenazine\">Valbenazine</a>, <a href=\"/wiki/Tetrabenazine\" title=\"Tetrabenazine\">tetrabenazine</a>, <a href=\"/wiki/Botulinum_toxin\" title=\"Botulinum toxin\">botulinum toxin</a><sup id=\"cite_ref-GARD2017_1-5\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-NIH2017_4-0\" class=\"reference\"><a href=\"#cite_note-NIH2017-4\">&#91;4&#93;</a></sup></td></tr><tr><th scope=\"row\">Prognosis</th><td>\nVariable<sup id=\"cite_ref-GARD2017_1-6\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup></td></tr><tr><th scope=\"row\">Frequency</th><td>\n20% (atypical antipsychotics) 30% (typical antipsychotics)<sup id=\"cite_ref-Car2017_5-0\" class=\"reference\"><a href=\"#cite_note-Car2017-5\">&#91;5&#93;</a></sup></td></tr></tbody></table>\n<p><b>Tardive dyskinesia</b> (<b>TD</b>) is a disorder that results in involuntary, repetitive body movements.<sup id=\"cite_ref-GARD2017_1-7\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup> This may include grimacing, sticking out the tongue, or smacking the lips.<sup id=\"cite_ref-GARD2017_1-8\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup> Additionally there may be <a href=\"/wiki/Chorea\" title=\"Chorea\">rapid jerking movements</a> or <a href=\"/wiki/Athetosis\" title=\"Athetosis\">slow writhing movements</a>.<sup id=\"cite_ref-GARD2017_1-9\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup> In about 20% of people, decreased functioning results.<sup id=\"cite_ref-Vi2016_3-1\" class=\"reference\"><a href=\"#cite_note-Vi2016-3\">&#91;3&#93;</a></sup>\n</p><p>Tardive dyskinesia occurs in some people as a result of long-term use of <a href=\"/wiki/Neuroleptic_medication\" class=\"mw-redirect\" title=\"Neuroleptic medication\">neuroleptic medications</a> (antipsychotics, <a href=\"/wiki/Metoclopramide\" title=\"Metoclopramide\">metoclopramide</a>).<sup id=\"cite_ref-GARD2017_1-10\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-NORD2015_2-2\" class=\"reference\"><a href=\"#cite_note-NORD2015-2\">&#91;2&#93;</a></sup> These medications are usually used for <a href=\"/wiki/Mental_illness\" class=\"mw-redirect\" title=\"Mental illness\">mental illness</a>, but may also be given for gastrointestinal or neurological problems.<sup id=\"cite_ref-GARD2017_1-11\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup> The condition typically develops only after months to years of use.<sup id=\"cite_ref-GARD2017_1-12\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Vi2016_3-2\" class=\"reference\"><a href=\"#cite_note-Vi2016-3\">&#91;3&#93;</a></sup> The diagnosis is based on the symptoms after ruling out other potential causes.<sup id=\"cite_ref-GARD2017_1-13\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup>\n</p><p>Efforts to prevent the condition include not using or using the lowest possible dose of neuroleptics.<sup id=\"cite_ref-Vi2016_3-3\" class=\"reference\"><a href=\"#cite_note-Vi2016-3\">&#91;3&#93;</a></sup> Treatment includes stopping the neuroleptic medication if possible or switching to <a href=\"/wiki/Clozapine\" title=\"Clozapine\">clozapine</a>.<sup id=\"cite_ref-GARD2017_1-14\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup> Other medications such as <a href=\"/wiki/Valbenazine\" title=\"Valbenazine\">valbenazine</a>, <a href=\"/wiki/Tetrabenazine\" title=\"Tetrabenazine\">tetrabenazine</a>, or <a href=\"/wiki/Botulinum_toxin\" title=\"Botulinum toxin\">botulinum toxin</a> may be used to lessen the symptoms.<sup id=\"cite_ref-GARD2017_1-15\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-NIH2017_4-1\" class=\"reference\"><a href=\"#cite_note-NIH2017-4\">&#91;4&#93;</a></sup> With treatment some see a resolution of symptoms while others do not.<sup id=\"cite_ref-GARD2017_1-16\" class=\"reference\"><a href=\"#cite_note-GARD2017-1\">&#91;1&#93;</a></sup>\n</p><p>Rates in those on <a href=\"/wiki/Atypical_antipsychotic\" title=\"Atypical antipsychotic\">atypical antipsychotics</a> are about 20%, while those on <a href=\"/wiki/Typical_antipsychotic\" title=\"Typical antipsychotic\">typical antipsychotics</a> have rates of about 30%.<sup id=\"cite_ref-Car2017_5-1\" class=\"reference\"><a href=\"#cite_note-Car2017-5\">&#91;5&#93;</a></sup> Risk is greater in older people.<sup id=\"cite_ref-Vi2016_3-4\" class=\"reference\"><a href=\"#cite_note-Vi2016-3\">&#91;3&#93;</a></sup> The term \"tardive dyskinesia\" first came into use in 1964.<sup id=\"cite_ref-Vi2016_3-5\" class=\"reference\"><a href=\"#cite_note-Vi2016-3\">&#91;3&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Signs_and_symptoms\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Signs and symptoms</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Causes\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Causes</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Risk_factors\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Risk factors</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Prevention\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Prevention</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Treatment\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Treatment</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Epidemiology\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Epidemiology</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#External_links\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Signs_and_symptoms\">Signs and symptoms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tardive_dyskinesia&amp;action=edit&amp;section=1\" title=\"Edit section: Signs and symptoms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Tardive dyskinesia is characterized by repetitive, involuntary movements. Some examples of these types of involuntary movements include:<sup id=\"cite_ref-MSR_6-0\" class=\"reference\"><a href=\"#cite_note-MSR-6\">&#91;6&#93;</a></sup>\n</p>\n<ul><li>Grimacing</li>\n<li>Tongue movements</li>\n<li>Lip smacking</li>\n<li>Lip puckering</li>\n<li>Pursing of the lips</li>\n<li>Excessive eye blinking</li></ul>\n<p>Rapid, involuntary movements of the limbs, torso, and fingers may also occur.<sup id=\"cite_ref-ninds.nih.gov_7-0\" class=\"reference\"><a href=\"#cite_note-ninds.nih.gov-7\">&#91;7&#93;</a></sup> In some cases, an individual's legs can be so affected that walking becomes difficult or impossible.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> These symptoms are the opposite of patients who are diagnosed with <a href=\"/wiki/Parkinson%27s_disease\" title=\"Parkinson&#39;s disease\">Parkinson's disease</a>. Parkinson's patients have difficulty moving, whereas tardive dyskinesia patients have difficulty not moving.<sup id=\"cite_ref-dukehealth.org_9-0\" class=\"reference\"><a href=\"#cite_note-dukehealth.org-9\">&#91;9&#93;</a></sup>\n</p><p>Respiratory irregularity, such as grunting and difficulty breathing, is another symptom associated with tardive dyskinesia, although studies have shown that the prevalence rate is relatively low.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p><p>Tardive dyskinesia is often misdiagnosed as a <a href=\"/wiki/Mental_illness\" class=\"mw-redirect\" title=\"Mental illness\">mental illness</a> rather than a <a href=\"/wiki/Neurological_disorder\" title=\"Neurological disorder\">neurological disorder</a>,<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> and as a result patients are prescribed <a href=\"/wiki/Neuroleptic\" class=\"mw-redirect\" title=\"Neuroleptic\">neuroleptic</a> drugs, which increase the probability that the patient will develop a severe and disabling case, and shortening the typical survival period.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup>\n</p><p>Other closely related neurological disorders have been recognized as variants of tardive dyskinesia. Tardive <a href=\"/wiki/Dystonia\" title=\"Dystonia\">dystonia</a> is similar to standard <a href=\"/wiki/Dystonia\" title=\"Dystonia\">dystonia</a> but permanent. Tardive <a href=\"/wiki/Akathisia\" title=\"Akathisia\">akathisia</a> involves painful feelings of inner tension and anxiety and a compulsive drive to move the body. In some extreme cases, afflicted individuals experience so much internal torture that they lose their ability to sit still. Tardive <a href=\"/wiki/Tourettism\" title=\"Tourettism\">tourettism</a> is a <a href=\"/wiki/Tic\" title=\"Tic\">tic</a> disorder featuring the same symptoms as <a href=\"/wiki/Tourette_syndrome\" title=\"Tourette syndrome\">Tourette syndrome</a>. The two disorders are extremely close in nature and often can only be differentiated by the details of their respective onsets. Tardive <a href=\"/wiki/Myoclonus\" title=\"Myoclonus\">myoclonus</a>, a rare disorder, presents as brief jerks of muscles in the face, neck, trunk, and extremities.<sup id=\"cite_ref-dukehealth.org_9-1\" class=\"reference\"><a href=\"#cite_note-dukehealth.org-9\">&#91;9&#93;</a></sup>\n</p><p>\"AIMS Examination\": This test is used when psychotropic medications have been prescribed because patients sometimes develop tardive dyskinesia due to prolonged use of antipsychotic medications. The Abnormal Involuntary Movement Scale (AIMS) examination is a test used to identify the symptoms of tardive dyskinesia (TD). The test is not meant to tell whether there is an absence or presence of tardive dyskinesia. It just scales to level of symptoms indicated by the actions observed. The levels range from none to severe. The AIMS examination was constructed in the 1970s to measure involuntary facial, trunk, and limb movements. It is best to do this test before and after the administration of the psychotropic drugs. Taking the AIMS consistently can help to track severity of TD over time.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Causes\">Causes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tardive_dyskinesia&amp;action=edit&amp;section=2\" title=\"Edit section: Causes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Tardive dyskinesia was first described in the 1950s shortly after the introduction of <a href=\"/wiki/Chlorpromazine\" title=\"Chlorpromazine\">chlorpromazine</a> and other <a href=\"/wiki/Antipsychotic_drugs\" class=\"mw-redirect\" title=\"Antipsychotic drugs\">antipsychotic drugs</a>.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> However, the exact mechanism of the disorder remains largely uncertain. The most compelling line of evidence suggests that tardive dyskinesia may result primarily from neuroleptic-induced <a href=\"/wiki/Dopamine\" title=\"Dopamine\">dopamine</a> supersensitivity in the <a href=\"/wiki/Nigrostriatal_pathway\" title=\"Nigrostriatal pathway\">nigrostriatal pathway</a>, with the D2 dopamine receptor being most affected. Neuroleptics act primarily on this dopamine system, and older neuroleptics, which have greater affinity for the D2 binding site, are associated with high risk for tardive dyskinesia.<sup id=\"cite_ref-hoerger_2007_16-0\" class=\"reference\"><a href=\"#cite_note-hoerger_2007-16\">&#91;16&#93;</a></sup> The D2 hypersensitivity hypothesis is also supported by evidence of a dose-response relationship, withdrawal effects, studies on D2 agonists and antagonists, animal studies, and genetic polymorphism research.<sup id=\"cite_ref-hoerger_2007_16-1\" class=\"reference\"><a href=\"#cite_note-hoerger_2007-16\">&#91;16&#93;</a></sup>\n</p><p>Given similar doses of the same neuroleptic, differences among individuals still exist in the likelihood of developing tardive dyskinesia. Such individual differences may be due to genetic polymorphisms, which code for D2 receptor binding site affinity, or prior exposure to environmental toxins. Decreased functional reserve or cognitive dysfunction, associated with aging, mental retardation, alcohol and drug abuse, or traumatic head injuries, has also been shown to increase risk of developing the disorder among those treated with neuroleptics.<sup id=\"cite_ref-hoerger_2007_16-2\" class=\"reference\"><a href=\"#cite_note-hoerger_2007-16\">&#91;16&#93;</a></sup> Antipsychotic drugs can sometimes camouflage the signs of tardive dyskinesia from occurring in the early stages; this can happen from the individual having an increased dose of an antipsychotic drug. Often the symptoms of tardive dyskinesia are not apparent until the individual comes off of the antipsychotic drugs; however, when tardive dyskinesia worsens, the signs become visible.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\n</p><p>Other dopamine antagonists and <a href=\"/wiki/Antiemetics\" class=\"mw-redirect\" title=\"Antiemetics\">antiemetics</a> can cause tardive dyskinesia, such as <a href=\"/wiki/Metoclopramide\" title=\"Metoclopramide\">metoclopramide</a> and <a href=\"/wiki/Promethazine\" title=\"Promethazine\">promethazine</a>, used to treat <a href=\"/wiki/Gastrointestinal_disorder\" class=\"mw-redirect\" title=\"Gastrointestinal disorder\">gastrointestinal disorders</a>. <a href=\"/wiki/Atypical_antipsychotic\" title=\"Atypical antipsychotic\">Atypical antipsychotics</a> are considered lower-risk for causing TD than their typical counterparts with their relative rates of TD of 13.1% and 32.4% respectively in short-term trials with haloperidol being the main typical antipsychotic utilised in said trials.<sup id=\"cite_ref-ET2013_18-0\" class=\"reference\"><a href=\"#cite_note-ET2013-18\">&#91;18&#93;</a></sup> Quetiapine and clozapine are considered the lowest risk agents for precipitating TD.<sup id=\"cite_ref-ET2013_18-1\" class=\"reference\"><a href=\"#cite_note-ET2013-18\">&#91;18&#93;</a></sup> From 2008, there have been reported cases of the anti-psychotic medication <a href=\"/wiki/Aripiprazole\" title=\"Aripiprazole\">aripiprazole</a>, a partial agonist at D2 receptors, leading to tardive dyskinesia.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>\nAs of 2013, reports of tardive dyskinesia in aripiprazole have grown in number.<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup>\nThe available research seems to suggest that the concurrent prophylactic use of a neuroleptic and an antiparkinsonian drug is useless to avoid early <a href=\"/wiki/Extrapyramidal_system\" title=\"Extrapyramidal system\">extrapyramidal</a> side-effects and may render the patient more sensitive to tardive dyskinesia. Since 1973 the use of these drugs has been found to be associated with the development of tardive dyskinesia.<sup id=\"cite_ref-crane_1973A_21-0\" class=\"reference\"><a href=\"#cite_note-crane_1973A-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-crane_1973B_22-0\" class=\"reference\"><a href=\"#cite_note-crane_1973B-22\">&#91;22&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Risk_factors\">Risk factors</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tardive_dyskinesia&amp;action=edit&amp;section=3\" title=\"Edit section: Risk factors\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>An increased risk of tardive dyskinesia has been associated with smoking in some studies,<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup> although a negative study does exist.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup> There seems to be a cigarette smoke-exposure-dependent risk for TD in antipsychotic-treated patients.<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup> Elderly patients are also at a heightened risk for developing TD,<sup id=\"cite_ref-MSR_6-1\" class=\"reference\"><a href=\"#cite_note-MSR-6\">&#91;6&#93;</a></sup> as are females and those with organic brain injuries or diabetes mellitus and those with the negative symptoms of schizophrenia.<sup id=\"cite_ref-ET2013_18-2\" class=\"reference\"><a href=\"#cite_note-ET2013-18\">&#91;18&#93;</a></sup> TD is also more common in those that experience acute neurological side effects from antipsychotic drug treatment.<sup id=\"cite_ref-ET2013_18-3\" class=\"reference\"><a href=\"#cite_note-ET2013-18\">&#91;18&#93;</a></sup> Racial discrepancies in TD rate also exist, with Africans and African Americans having higher rates of TD after exposure to antipsychotics.<sup id=\"cite_ref-MSR_6-2\" class=\"reference\"><a href=\"#cite_note-MSR-6\">&#91;6&#93;</a></sup> Certain genetic risk factors for TD have been identified including <a href=\"/wiki/Polymorphism_(biology)\" title=\"Polymorphism (biology)\">polymorphisms</a> in the genes encoding the <a href=\"/wiki/Dopamine_D3_receptor\" class=\"mw-redirect\" title=\"Dopamine D3 receptor\">D<sub>3</sub></a>, <a href=\"/wiki/5-HT2A_receptor\" title=\"5-HT2A receptor\">5-HT<sub>2A</sub></a> and <a href=\"/wiki/5-HT2C_receptor\" title=\"5-HT2C receptor\">5-HT<sub>2C</sub></a> receptors.<sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Prevention\">Prevention</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tardive_dyskinesia&amp;action=edit&amp;section=4\" title=\"Edit section: Prevention\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Prevention of tardive dyskinesia is achieved by using the lowest effective dose of a <a href=\"/wiki/Neuroleptic\" class=\"mw-redirect\" title=\"Neuroleptic\">neuroleptic</a> for the shortest time. However, with diseases of chronic psychosis such as schizophrenia, this strategy must be balanced with the fact that increased dosages of neuroleptics are more beneficial in preventing recurrence of psychosis. If tardive dyskinesia is diagnosed, the causative drug should be discontinued. Tardive dyskinesia may persist after withdrawal of the drug for months, years or even permanently.<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup><sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup> Some studies suggest that physicians should consider using <a href=\"/wiki/Atypical_antipsychotic\" title=\"Atypical antipsychotic\">atypical antipsychotics</a> as a substitute to <a href=\"/wiki/Typical_antipsychotic\" title=\"Typical antipsychotic\">typical antipsychotics</a> for patients requiring medication. These agents are associated with fewer neuromotor side effects and a lower risk of developing tardive dyskinesia.<sup id=\"cite_ref-pmid16001096_30-0\" class=\"reference\"><a href=\"#cite_note-pmid16001096-30\">&#91;30&#93;</a></sup>\n</p><p>Studies have tested the use of <a href=\"/wiki/Melatonin\" title=\"Melatonin\">melatonin</a>, high dosage <a href=\"/wiki/Vitamins\" class=\"mw-redirect\" title=\"Vitamins\">vitamins</a>, and different <a href=\"/wiki/Antioxidants\" class=\"mw-redirect\" title=\"Antioxidants\">antioxidants</a> in concurrence with antipsychotic drugs (often used to treat <a href=\"/wiki/Schizophrenia\" title=\"Schizophrenia\">schizophrenia</a>) as a way of preventing and treating tardive dyskinesia. Although further research is needed, studies reported a much lower percentage of individuals developing tardive dyskinesia than the current prevalence rate for those taking antipsychotic drugs.<sup id=\"cite_ref-Lerner,_V._2011_pp._109\u201334_31-0\" class=\"reference\"><a href=\"#cite_note-Lerner,_V._2011_pp._109\u201334-31\">&#91;31&#93;</a></sup> Tentative evidence supports the use of <a href=\"/wiki/Vitamin_E\" title=\"Vitamin E\">vitamin E</a> for prevention.<sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Treatment\">Treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tardive_dyskinesia&amp;action=edit&amp;section=5\" title=\"Edit section: Treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><a href=\"/wiki/Valbenazine\" title=\"Valbenazine\">Valbenazine</a> was approved by the <a href=\"/wiki/FDA\" class=\"mw-redirect\" title=\"FDA\">FDA</a> for tardive dyskinesia in April 2017.<sup id=\"cite_ref-FDAApprove_33-0\" class=\"reference\"><a href=\"#cite_note-FDAApprove-33\">&#91;33&#93;</a></sup> <a href=\"/wiki/Tetrabenazine\" title=\"Tetrabenazine\">Tetrabenazine</a>, which is a dopamine depleting drug, is sometimes used to treat tardive dyskinesia and other movement disorders (e.g. Huntington's chorea).<sup id=\"cite_ref-ninds.nih.gov_7-1\" class=\"reference\"><a href=\"#cite_note-ninds.nih.gov-7\">&#91;7&#93;</a></sup> <a href=\"/wiki/Deutetrabenazine\" title=\"Deutetrabenazine\">Deutetrabenazine</a>, an <a href=\"/wiki/Isotopomers\" title=\"Isotopomers\">isotopic isomer</a> of tetrabenazine, was approved by the FDA for tardive dyskinesia in August 2017.<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup> <a href=\"/wiki/Vitamin_B6\" title=\"Vitamin B6\">Vitamin B6</a> has been reported to be an effective treatment for TD in two randomised double-blind placebo-controlled trials,<sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup> but the overall evidence for its effectiveness is considered \"weak.\"<sup id=\"cite_ref-Adelufosi_Cochrane_37-0\" class=\"reference\"><a href=\"#cite_note-Adelufosi_Cochrane-37\">&#91;37&#93;</a></sup> <a href=\"/wiki/Clonidine\" title=\"Clonidine\">Clonidine</a> may also be useful in the treatment of TD, although dose-limiting hypotension and sedation may hinder its usage.<sup id=\"cite_ref-TD2011_38-0\" class=\"reference\"><a href=\"#cite_note-TD2011-38\">&#91;38&#93;</a></sup> <a href=\"/wiki/Botox\" class=\"mw-redirect\" title=\"Botox\">Botox</a> injections are used for minor focal dystonia, but not in more advanced tardive dyskinesia.<sup id=\"cite_ref-MSR_6-3\" class=\"reference\"><a href=\"#cite_note-MSR-6\">&#91;6&#93;</a></sup> As of 2018 evidence is insufficient to support the use of <a href=\"/wiki/Benzodiazepines\" class=\"mw-redirect\" title=\"Benzodiazepines\">benzodiazepines</a>, <a href=\"/wiki/Baclofen\" title=\"Baclofen\">baclofen</a>, <a href=\"/wiki/Progabide\" title=\"Progabide\">progabide</a>, <a href=\"/wiki/Sodium_valproate\" class=\"mw-redirect\" title=\"Sodium valproate\">sodium valproate</a>, <a href=\"/wiki/Tetrahydroisoxazolopyridinol\" class=\"mw-redirect\" title=\"Tetrahydroisoxazolopyridinol\">tetrahydroisoxazolopyridinol</a>, or <a href=\"/wiki/Calcium_channel_blockers\" class=\"mw-redirect\" title=\"Calcium channel blockers\">calcium channel blockers</a> (e.g. <a href=\"/wiki/Diltiazem\" title=\"Diltiazem\">diltiazem</a>).<sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup><sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup><sup id=\"cite_ref-Essali_et_al_Cochrane_41-0\" class=\"reference\"><a href=\"#cite_note-Essali_et_al_Cochrane-41\">&#91;41&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Epidemiology\">Epidemiology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tardive_dyskinesia&amp;action=edit&amp;section=6\" title=\"Edit section: Epidemiology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Tardive dyskinesia most commonly occurs in patients with psychiatric conditions who are treated with <a href=\"/wiki/Antipsychotic\" title=\"Antipsychotic\">antipsychotic</a> medications for many years. The average prevalence rate has been estimated to be around 30% for individuals taking antipsychotic medication, such as that used to treat schizophrenia.<sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup> A study being conducted at the Yale University School of Medicine has estimated that \"32% of patients develop persistent tics after 5 years on major tranquilizers, 57% by 15 years, and 68% by 25 years.\"<sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup> More drastic data was found during a longitudinal study conducted on individuals 45 years of age and older who were taking antipsychotic drugs. According to this research study, 26% of patients developed tardive dyskinesia after just one year on the medication. Another 60% of this at-risk group developed the disorder after 3 years, and 23% developed <i>severe</i> cases of tardive dyskinesia within 3 years.<sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup> According to these estimates, the majority of patients will eventually develop the disorder if they remain on the drugs long enough.<sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup>\n</p><p>Elderly patients are more prone to develop tardive dyskinesia, and elderly women are more at-risk than elderly men. The risk is much lower for younger men and women, and also more equal across the sexes.<sup id=\"cite_ref-46\" class=\"reference\"><a href=\"#cite_note-46\">&#91;46&#93;</a></sup> Patients who have undergone <a href=\"/wiki/Electroconvulsive_therapy\" title=\"Electroconvulsive therapy\">electroconvulsive therapy</a> or have a history of diabetes or alcohol abuse also have a higher risk of developing tardive dyskinesia.<sup id=\"cite_ref-pmid16001096_30-1\" class=\"reference\"><a href=\"#cite_note-pmid16001096-30\">&#91;30&#93;</a></sup>\n</p><p>Several studies have recently been conducted comparing the prevalence rate of tardive dyskinesia with second generation, or more modern, antipsychotic drugs to that of first generation drugs. The newer antipsychotics appear to have a substantially reduced potential for causing tardive dyskinesia. However, some studies express concern that the prevalence rate has decreased far less than expected, cautioning against the overestimation of the safety of modern antipsychotics.<sup id=\"cite_ref-Lerner,_V._2011_pp._109\u201334_31-1\" class=\"reference\"><a href=\"#cite_note-Lerner,_V._2011_pp._109\u201334-31\">&#91;31&#93;</a></sup><sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup>\n</p><p>A physician can evaluate and diagnose a patient with tardive dyskinesia by conducting a systematic examination. The physician should ask the patient to relax, and look for symptoms like facial grimacing, eye or lip movements, tics, respiratory irregularities, and tongue movements. In some cases, patients experience nutritional problems, so a physician can also look for a gain or loss in weight.<sup id=\"cite_ref-pmid16001096_30-2\" class=\"reference\"><a href=\"#cite_note-pmid16001096-30\">&#91;30&#93;</a></sup>\n</p><p>Apart from the underlying psychiatric disorder, tardive dyskinesia may cause afflicted people to become socially isolated. It also increases the risk of <a href=\"/wiki/Body_dysmorphic_disorder\" title=\"Body dysmorphic disorder\">body dysmorphic disorder</a> (BDD) and can even lead to suicide. Emotional or physical stress can increase the severity of dyskinetic movements, whereas relaxation and sedation have the opposite effect.<sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tardive_dyskinesia&amp;action=edit&amp;section=7\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-GARD2017-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-GARD2017_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-GARD2017_1-16\"><sup><i><b>q</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://rarediseases.info.nih.gov/diseases/7732/tardive-dyskinesia\">\"Tardive dyskinesia\"</a>. <i>rarediseases.info.nih.gov</i>. 1 June 2017. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170618062648/https://rarediseases.info.nih.gov/diseases/7732/tardive-dyskinesia\">Archived</a> from the original on 18 June 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 June</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=rarediseases.info.nih.gov&amp;rft.atitle=Tardive+dyskinesia&amp;rft.date=2017-06-01&amp;rft_id=https%3A%2F%2Frarediseases.info.nih.gov%2Fdiseases%2F7732%2Ftardive-dyskinesia&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-NORD2015-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NORD2015_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NORD2015_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-NORD2015_2-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://rarediseases.org/rare-diseases/tardive-dyskinesia/\">\"Tardive Dyskinesia\"</a>. <i>NORD (National Organization for Rare Disorders)</i>. 2015. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170828234422/https://rarediseases.org/rare-diseases/tardive-dyskinesia/\">Archived</a> from the original on 28 August 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">11 June</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NORD+%28National+Organization+for+Rare+Disorders%29&amp;rft.atitle=Tardive+Dyskinesia&amp;rft.date=2015&amp;rft_id=https%3A%2F%2Frarediseases.org%2Frare-diseases%2Ftardive-dyskinesia%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Vi2016-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Vi2016_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Vi2016_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Vi2016_3-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Vi2016_3-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Vi2016_3-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Vi2016_3-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vijayakumar, D; Jankovic, J (May 2016). \"Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia\". <i>Drugs</i>. <b>76</b> (7): 779\u201387. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s40265-016-0568-1\">10.1007/s40265-016-0568-1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27091214\">27091214</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drugs&amp;rft.atitle=Drug-Induced+Dyskinesia%2C+Part+2%3A+Treatment+of+Tardive+Dyskinesia.&amp;rft.volume=76&amp;rft.issue=7&amp;rft.pages=779-87&amp;rft.date=2016-05&amp;rft_id=info%3Adoi%2F10.1007%2Fs40265-016-0568-1&amp;rft_id=info%3Apmid%2F27091214&amp;rft.aulast=Vijayakumar&amp;rft.aufirst=D&amp;rft.au=Jankovic%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-NIH2017-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NIH2017_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NIH2017_4-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ninds.nih.gov/Disorders/All-Disorders/Tardive-Dyskinesia-Information-Page#disorders-r1\">\"Tardive Dyskinesia Information Page\"</a>. <i>National Institute of Neurological Disorders and Stroke</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170704205427/https://www.ninds.nih.gov/Disorders/All-Disorders/Tardive-Dyskinesia-Information-Page#disorders-r1\">Archived</a> from the original on 2017-07-04.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Institute+of+Neurological+Disorders+and+Stroke&amp;rft.atitle=Tardive+Dyskinesia+Information+Page&amp;rft_id=https%3A%2F%2Fwww.ninds.nih.gov%2FDisorders%2FAll-Disorders%2FTardive-Dyskinesia-Information-Page%23disorders-r1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Car2017-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Car2017_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Car2017_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Carbon, M; Hsieh, CH; Kane, JM; Correll, CU (March 2017). \"Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis\". <i>The Journal of Clinical Psychiatry</i>. <b>78</b> (3): e264\u2013e278. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4088/jcp.16r10832\">10.4088/jcp.16r10832</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28146614\">28146614</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Clinical+Psychiatry&amp;rft.atitle=Tardive+Dyskinesia+Prevalence+in+the+Period+of+Second-Generation+Antipsychotic+Use%3A+A+Meta-Analysis.&amp;rft.volume=78&amp;rft.issue=3&amp;rft.pages=e264-e278&amp;rft.date=2017-03&amp;rft_id=info%3Adoi%2F10.4088%2Fjcp.16r10832&amp;rft_id=info%3Apmid%2F28146614&amp;rft.aulast=Carbon&amp;rft.aufirst=M&amp;rft.au=Hsieh%2C+CH&amp;rft.au=Kane%2C+JM&amp;rft.au=Correll%2C+CU&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-MSR-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-MSR_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-MSR_6-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-MSR_6-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-MSR_6-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://emedicine.medscape.com/article/1151826-overview#showall\">\"Tardive Dyskinesia\"</a>. <i>Medscape Reference</i>. WebMD. 9 February 2012. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20131203011126/http://emedicine.medscape.com/article/1151826-overview#showall\">Archived</a> from the original on 3 December 2013<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">25 November</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Medscape+Reference&amp;rft.atitle=Tardive+Dyskinesia&amp;rft.date=2012-02-09&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F1151826-overview%23showall&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ninds.nih.gov-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ninds.nih.gov_7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ninds.nih.gov_7-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">National Institutes of Health, National Institute of Neurological Disorders and Stroke. (2011). Ninds tardive dyskinesia information page. Retrieved from website: <cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ninds.nih.gov/disorders/tardive/tardive.htm\">\"Archived copy\"</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20120427104252/http://www.ninds.nih.gov/disorders/tardive/tardive.htm\">Archived</a> from the original on 2012-04-27<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-05-01</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.ninds.nih.gov%2Fdisorders%2Ftardive%2Ftardive.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\">Nasrallah, H. (2003, Sept). Tardive dyskinesia. Retrieved from <cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20120421140945/http://www.nami.org/Content/ContentGroups/Helpline1/Tardive_Dyskinesia.htm\">\"Archived copy\"</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nami.org/Content/ContentGroups/Helpline1/Tardive_Dyskinesia.htm\">the original</a> on 2012-04-21<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-05-01</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.nami.org%2FContent%2FContentGroups%2FHelpline1%2FTardive_Dyskinesia.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-dukehealth.org-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-dukehealth.org_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-dukehealth.org_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Duke University Health System. (2010, May 17). Additional movement disorders. Retrieved from <cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.dukehealth.org/services/neurological_disorders/care_guides/additional_movement_disorders/\">\"Archived copy\"</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20120524065319/http://www.dukehealth.org/services/neurological_disorders/care_guides/additional_movement_disorders\">Archived</a> from the original on 2012-05-24<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-05-01</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.dukehealth.org%2Fservices%2Fneurological_disorders%2Fcare_guides%2Fadditional_movement_disorders%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yassa, R.; Lal, S. (1986). \"Respiratory irregularity and tardive dyskinesia a prevalence study\". <i>Acta Psychiatrica Scandinavica</i>. <b>73</b> (5): 506\u201310. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1600-0447.1986.tb02717.x\">10.1111/j.1600-0447.1986.tb02717.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/2875609\">2875609</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Psychiatrica+Scandinavica&amp;rft.atitle=Respiratory+irregularity+and+tardive+dyskinesia+a+prevalence+study&amp;rft.volume=73&amp;rft.issue=5&amp;rft.pages=506-10&amp;rft.date=1986&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0447.1986.tb02717.x&amp;rft_id=info%3Apmid%2F2875609&amp;rft.aulast=Yassa&amp;rft.aufirst=R.&amp;rft.au=Lal%2C+S.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yassa, Ramzy; Jones, Barry D. (1985). \"Complications of tardive dyskinesia: A review\". <i>Psychosomatics</i>. <b>26</b> (4): 305\u20137, 310, 312\u20133. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0033-3182%2885%2972863-0\">10.1016/S0033-3182(85)72863-0</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/2859630\">2859630</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychosomatics&amp;rft.atitle=Complications+of+tardive+dyskinesia%3A+A+review&amp;rft.volume=26&amp;rft.issue=4&amp;rft.pages=305-7%2C+310%2C+312-3&amp;rft.date=1985&amp;rft_id=info%3Adoi%2F10.1016%2FS0033-3182%2885%2972863-0&amp;rft_id=info%3Apmid%2F2859630&amp;rft.aulast=Yassa&amp;rft.aufirst=Ramzy&amp;rft.au=Jones%2C+Barry+D.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Dean, C. E.; Thuras, P. D. (2009). \"Mortality and tardive dyskinesia: Long-term study using the US National Death Index\". <i>The British Journal of Psychiatry</i>. <b>194</b> (4): 360\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1192/bjp.bp.108.049395\">10.1192/bjp.bp.108.049395</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19336789\">19336789</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+British+Journal+of+Psychiatry&amp;rft.atitle=Mortality+and+tardive+dyskinesia%3A+Long-term+study+using+the+US+National+Death+Index&amp;rft.volume=194&amp;rft.issue=4&amp;rft.pages=360-4&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1192%2Fbjp.bp.108.049395&amp;rft_id=info%3Apmid%2F19336789&amp;rft.aulast=Dean&amp;rft.aufirst=C.+E.&amp;rft.au=Thuras%2C+P.+D.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\">Encyclopedia of Mental Disorders<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citing_sources#What_information_to_include\" title=\"Wikipedia:Citing sources\"><span title=\"A complete citation is needed (March 2018)\">full citation needed</span></a></i>&#93;</sup></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\">Montana State Hospital<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citing_sources#What_information_to_include\" title=\"Wikipedia:Citing sources\"><span title=\"A complete citation is needed (March 2018)\">full citation needed</span></a></i>&#93;</sup></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Baldessarini, Ross J. (1988). \"A summary of current knowledge of tardive dyskinesia\". <i>L'Enc\u00e9phale</i>. <b>14</b> (Spec Issue): 263\u20138. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/2905654\">2905654</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=L%27Enc%C3%A9phale&amp;rft.atitle=A+summary+of+current+knowledge+of+tardive+dyskinesia&amp;rft.volume=14&amp;rft.issue=Spec+Issue&amp;rft.pages=263-8&amp;rft.date=1988&amp;rft_id=info%3Apmid%2F2905654&amp;rft.aulast=Baldessarini&amp;rft.aufirst=Ross+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-hoerger_2007-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-hoerger_2007_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-hoerger_2007_16-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-hoerger_2007_16-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Hoerger, Michael. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.priory.com/tardive-dyskinesia.htm\">\"The primacy of neuroleptic-Induced D2 receptor hypersensitivity in tardive dyskinesia\"</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20080118011913/http://www.priory.com/tardive-dyskinesia.htm\">Archived</a> from the original on 2008-01-18.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+primacy+of+neuroleptic-Induced+D2+receptor+hypersensitivity+in+tardive+dyskinesia&amp;rft.aulast=Hoerger&amp;rft.aufirst=Michael&amp;rft_id=http%3A%2F%2Fwww.priory.com%2Ftardive-dyskinesia.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources_(medicine)\" title=\"Wikipedia:Identifying reliable sources (medicine)\"><span title=\"Material near this tag may rely on an unreliable or less reliable medical source. (June 2012)\">unreliable medical source?</span></a></i>&#93;</sup></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Ross, Colin A; Read, John (2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=SomdZ-8jnVgC&amp;pg=PA101\">\"Antipsychotic medication: myths and facts\"</a>.  In Read, John; Mosher, Loren R.; Bentall, Richard P. <i>Models of Madness: Psychological, Social and Biological Approaches to Schizophrenia</i>. London: Brunner-Routledge. pp.&#160;101\u201314. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-58391-906-4\" title=\"Special:BookSources/978-1-58391-906-4\">978-1-58391-906-4</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Antipsychotic+medication%3A+myths+and+facts&amp;rft.btitle=Models+of+Madness%3A+Psychological%2C+Social+and+Biological+Approaches+to+Schizophrenia&amp;rft.place=London&amp;rft.pages=101-14&amp;rft.pub=Brunner-Routledge&amp;rft.date=2004&amp;rft.isbn=978-1-58391-906-4&amp;rft.aulast=Ross&amp;rft.aufirst=Colin+A&amp;rft.au=Read%2C+John&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DSomdZ-8jnVgC%26pg%3DPA101&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ET2013-18\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ET2013_18-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ET2013_18-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ET2013_18-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-ET2013_18-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rana, Abdul Qayyum; Chaudry, Zishan; Blanchet, Pierre (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3825689\">\"New and emerging treatments for symptomatic tardive dyskinesia\"</a>. <i>Drug Design, Development and Therapy</i>. <b>7</b>: 1329\u201340. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2147/DDDT.S32328\">10.2147/DDDT.S32328</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3825689\">3825689</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24235816\">24235816</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Design%2C+Development+and+Therapy&amp;rft.atitle=New+and+emerging+treatments+for+symptomatic+tardive+dyskinesia&amp;rft.volume=7&amp;rft.pages=1329-40&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3825689&amp;rft_id=info%3Apmid%2F24235816&amp;rft_id=info%3Adoi%2F10.2147%2FDDDT.S32328&amp;rft.aulast=Rana&amp;rft.aufirst=Abdul+Qayyum&amp;rft.au=Chaudry%2C+Zishan&amp;rft.au=Blanchet%2C+Pierre&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3825689&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Alexander, C; Power, P (2008). \"A case of aripiprazole and tardive dyskinesia\". <i>Journal of Psychopharmacology</i>. <b>23</b> (2): 214\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/0269881108089591\">10.1177/0269881108089591</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18515468\">18515468</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Psychopharmacology&amp;rft.atitle=A+case+of+aripiprazole+and+tardive+dyskinesia&amp;rft.volume=23&amp;rft.issue=2&amp;rft.pages=214-5&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1177%2F0269881108089591&amp;rft_id=info%3Apmid%2F18515468&amp;rft.aulast=Alexander&amp;rft.aufirst=C&amp;rft.au=Power%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Alexander, J (Mar 2013). \"Aripiprazole induced tardive dyskinesia-accruing evidence\". <i>Aust N Z J Psychiatry</i>. <b>47</b> (3): 289\u201390. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/0004867412461058\">10.1177/0004867412461058</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22990431\">22990431</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Aust+N+Z+J+Psychiatry&amp;rft.atitle=Aripiprazole+induced+tardive+dyskinesia-accruing+evidence&amp;rft.volume=47&amp;rft.issue=3&amp;rft.pages=289-90&amp;rft.date=2013-03&amp;rft_id=info%3Adoi%2F10.1177%2F0004867412461058&amp;rft_id=info%3Apmid%2F22990431&amp;rft.aulast=Alexander&amp;rft.aufirst=J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-crane_1973A-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-crane_1973A_21-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Crane, GE (1973). \"Is tardive dyskinesia a drug effect?\". <i>The American Journal of Psychiatry</i>. <b>130</b> (9): 1043\u201344. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1176/ajp.130.9.1043-a\">10.1176/ajp.130.9.1043-a</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/4727768\">4727768</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.atitle=Is+tardive+dyskinesia+a+drug+effect%3F&amp;rft.volume=130&amp;rft.issue=9&amp;rft.pages=1043-44&amp;rft.date=1973&amp;rft_id=info%3Adoi%2F10.1176%2Fajp.130.9.1043-a&amp;rft_id=info%3Apmid%2F4727768&amp;rft.aulast=Crane&amp;rft.aufirst=GE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-crane_1973B-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-crane_1973B_22-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Crane, George E (1973). \"Rapid Reversal of Tardive Dyskinesia\". <i>American Journal of Psychiatry</i>. <b>130</b> (10): 1159. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1176/ajp.130.10.1159\">10.1176/ajp.130.10.1159</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/4728916\">4728916</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Psychiatry&amp;rft.atitle=Rapid+Reversal+of+Tardive+Dyskinesia&amp;rft.volume=130&amp;rft.issue=10&amp;rft.pages=1159&amp;rft.date=1973&amp;rft_id=info%3Adoi%2F10.1176%2Fajp.130.10.1159&amp;rft_id=info%3Apmid%2F4728916&amp;rft.aulast=Crane&amp;rft.aufirst=George+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yassa, R; Lal, S; Korpassy, A; Ally, J (January 1987). \"Nicotine exposure and tardive dyskinesia\". <i>Biological Psychiatry</i>. <b>22</b> (1): 67\u201372. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/0006-3223%2887%2990131-4\">10.1016/0006-3223(87)90131-4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/3790642\">3790642</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biological+Psychiatry&amp;rft.atitle=Nicotine+exposure+and+tardive+dyskinesia&amp;rft.volume=22&amp;rft.issue=1&amp;rft.pages=67-72&amp;rft.date=1987-01&amp;rft_id=info%3Adoi%2F10.1016%2F0006-3223%2887%2990131-4&amp;rft_id=info%3Apmid%2F3790642&amp;rft.au=Yassa%2C+R&amp;rft.au=Lal%2C+S&amp;rft.au=Korpassy%2C+A&amp;rft.au=Ally%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chong, SA; Tan, EC; Tan, CH; Mythily (May 2003). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC161742\">\"Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene\"</a>. <i>J Psychiatry Neurosci</i>. <b>28</b> (3): 185\u201389. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC161742\">161742</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12790158\">12790158</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Psychiatry+Neurosci&amp;rft.atitle=Smoking+and+tardive+dyskinesia%3A+lack+of+involvement+of+the+CYP1A2+gene&amp;rft.volume=28&amp;rft.issue=3&amp;rft.pages=185-89&amp;rft.date=2003-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC161742&amp;rft_id=info%3Apmid%2F12790158&amp;rft.au=Chong%2C+SA&amp;rft.au=Tan%2C+EC&amp;rft.au=Tan%2C+CH&amp;rft.au=Mythily&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC161742&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zhang, XY; Yu, YQ; Sun, S; Zhang, X; Li, W; Xiu, MH; Chen da, C; Yang, FD; Zhu, F; Kosten, TA; Kosten, TR (August 2011). \"Smoking and tardive dyskinesia in male patients with chronic schizophrenia\". <i>Progress in Neuro-Psychopharmacology and Biological Psychiatry</i>. <b>35</b> (7): 1765\u201369. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.pnpbp.2011.06.006\">10.1016/j.pnpbp.2011.06.006</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21723906\">21723906</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Progress+in+Neuro-Psychopharmacology+and+Biological+Psychiatry&amp;rft.atitle=Smoking+and+tardive+dyskinesia+in+male+patients+with+chronic+schizophrenia&amp;rft.volume=35&amp;rft.issue=7&amp;rft.pages=1765-69&amp;rft.date=2011-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pnpbp.2011.06.006&amp;rft_id=info%3Apmid%2F21723906&amp;rft.au=Zhang%2C+XY&amp;rft.au=Yu%2C+YQ&amp;rft.au=Sun%2C+S&amp;rft.au=Zhang%2C+X&amp;rft.au=Li%2C+W&amp;rft.au=Xiu%2C+MH&amp;rft.au=Chen+da%2C+C&amp;rft.au=Yang%2C+FD&amp;rft.au=Zhu%2C+F&amp;rft.au=Kosten%2C+TA&amp;rft.au=Kosten%2C+TR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Diehl, A; Reinhard, I; Schmitt, A; Mann, K; Gattaz, WF (January 2009). \"Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial\". <i>European Psychiatry</i>. <b>24</b> (1): 33\u201340. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.eurpsy.2008.07.007\">10.1016/j.eurpsy.2008.07.007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18774276\">18774276</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Psychiatry&amp;rft.atitle=Does+the+degree+of+smoking+effect+the+severity+of+tardive+dyskinesia%3F+A+longitudinal+clinical+trial&amp;rft.volume=24&amp;rft.issue=1&amp;rft.pages=33-40&amp;rft.date=2009-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eurpsy.2008.07.007&amp;rft_id=info%3Apmid%2F18774276&amp;rft.au=Diehl%2C+A&amp;rft.au=Reinhard%2C+I&amp;rft.au=Schmitt%2C+A&amp;rft.au=Mann%2C+K&amp;rft.au=Gattaz%2C+WF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Segman, Ronnen H; Heresco-Levy, Uriel; Finkel, Boris; Inbar, Roi; Neeman, Tal; Schlafman, Michael; Dorevitch, Abe; Yakir, Avraham; Lerner, Arturo; Goltser, Tanya; Shelevoy, Aida; Lerer, Bernard (2000). \"Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: Additive contribution of 5-HT2C ser and DRD3 gly alleles to susceptibility\". <i>Psychopharmacology</i>. <b>152</b> (4): 408\u201313. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s002130000521\">10.1007/s002130000521</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11140333\">11140333</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychopharmacology&amp;rft.atitle=Association+between+the+serotonin+2C+receptor+gene+and+tardive+dyskinesia+in+chronic+schizophrenia%3A+Additive+contribution+of+5-HT2C+ser+and+DRD3+gly+alleles+to+susceptibility&amp;rft.volume=152&amp;rft.issue=4&amp;rft.pages=408-13&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1007%2Fs002130000521&amp;rft_id=info%3Apmid%2F11140333&amp;rft.aulast=Segman&amp;rft.aufirst=Ronnen+H&amp;rft.au=Heresco-Levy%2C+Uriel&amp;rft.au=Finkel%2C+Boris&amp;rft.au=Inbar%2C+Roi&amp;rft.au=Neeman%2C+Tal&amp;rft.au=Schlafman%2C+Michael&amp;rft.au=Dorevitch%2C+Abe&amp;rft.au=Yakir%2C+Avraham&amp;rft.au=Lerner%2C+Arturo&amp;rft.au=Goltser%2C+Tanya&amp;rft.au=Shelevoy%2C+Aida&amp;rft.au=Lerer%2C+Bernard&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rauchverger, B; Isakov, V; Jabarin, M (2007). \"Olanzapine-Induced Tardive Dystonia Successfully Treated by Tetrabenazine\". <i>Journal of Neuropsychiatry</i>. <b>19</b> (4): 484\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1176/appi.neuropsych.19.4.484-a\">10.1176/appi.neuropsych.19.4.484-a</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18070868\">18070868</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuropsychiatry&amp;rft.atitle=Olanzapine-Induced+Tardive+Dystonia+Successfully+Treated+by+Tetrabenazine&amp;rft.volume=19&amp;rft.issue=4&amp;rft.pages=484-5&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1176%2Fappi.neuropsych.19.4.484-a&amp;rft_id=info%3Apmid%2F18070868&amp;rft.aulast=Rauchverger&amp;rft.aufirst=B&amp;rft.au=Isakov%2C+V&amp;rft.au=Jabarin%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fernandez, Hubert H; Friedman, Joseph H (2003). \"Classification and Treatment of Tardive Syndromes\". <i>The Neurologist</i>. <b>9</b> (1): 16\u201327. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/01.nrl.0000038585.58012.97\">10.1097/01.nrl.0000038585.58012.97</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12801428\">12801428</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Neurologist&amp;rft.atitle=Classification+and+Treatment+of+Tardive+Syndromes&amp;rft.volume=9&amp;rft.issue=1&amp;rft.pages=16-27&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1097%2F01.nrl.0000038585.58012.97&amp;rft_id=info%3Apmid%2F12801428&amp;rft.aulast=Fernandez&amp;rft.aufirst=Hubert+H&amp;rft.au=Friedman%2C+Joseph+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid16001096-30\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid16001096_30-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid16001096_30-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid16001096_30-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Saltz, Bruce L.; Robinson, Delbert G.; Woerner, Margaret G. (2004). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC487007\">\"Recognizing and Managing Antipsychotic Drug Treatment Side Effects in the Elderly\"</a>. <i>Primary Care Companion to the Journal of Clinical Psychiatry</i>. <b>6</b> (Suppl 2): 14\u20139. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC487007\">487007</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16001096\">16001096</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Primary+Care+Companion+to+the+Journal+of+Clinical+Psychiatry&amp;rft.atitle=Recognizing+and+Managing+Antipsychotic+Drug+Treatment+Side+Effects+in+the+Elderly&amp;rft.volume=6&amp;rft.issue=Suppl+2&amp;rft.pages=14-9&amp;rft.date=2004&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC487007&amp;rft_id=info%3Apmid%2F16001096&amp;rft.aulast=Saltz&amp;rft.aufirst=Bruce+L.&amp;rft.au=Robinson%2C+Delbert+G.&amp;rft.au=Woerner%2C+Margaret+G.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC487007&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Lerner,_V._2011_pp._109\u201334-31\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Lerner,_V._2011_pp._109\u201334_31-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Lerner,_V._2011_pp._109\u201334_31-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Lerner, Vladimir (2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=SJLrIa7yFBgC&amp;pg=PA109\">\"Antioxidants as a Treatment and Prevention of Tardive Dyskinesia\"</a>.  In Ritsner, Michael S. <i>Handbook of Schizophrenia Spectrum Disorders, Volume III</i>. pp.&#160;109\u201334. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/978-94-007-0834-1_6\">10.1007/978-94-007-0834-1_6</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-94-007-0833-4\" title=\"Special:BookSources/978-94-007-0833-4\">978-94-007-0833-4</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Antioxidants+as+a+Treatment+and+Prevention+of+Tardive+Dyskinesia&amp;rft.btitle=Handbook+of+Schizophrenia+Spectrum+Disorders%2C+Volume+III&amp;rft.pages=109-34&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1007%2F978-94-007-0834-1_6&amp;rft.isbn=978-94-007-0833-4&amp;rft.aulast=Lerner&amp;rft.aufirst=Vladimir&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DSJLrIa7yFBgC%26pg%3DPA109&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Soares-Weiser, K; Maayan, N; Bergman, H (17 January 2018). \"Vitamin E for antipsychotic-induced tardive dyskinesia\". <i>The Cochrane Database of Systematic Reviews</i>. <b>1</b>: CD000209. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD000209.pub3\">10.1002/14651858.CD000209.pub3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29341067\">29341067</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Vitamin+E+for+antipsychotic-induced+tardive+dyskinesia.&amp;rft.volume=1&amp;rft.pages=CD000209&amp;rft.date=2018-01-17&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD000209.pub3&amp;rft_id=info%3Apmid%2F29341067&amp;rft.aulast=Soares-Weiser&amp;rft.aufirst=K&amp;rft.au=Maayan%2C+N&amp;rft.au=Bergman%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-FDAApprove-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-FDAApprove_33-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Commissioner, Office of the. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm552418.htm\">\"Press Announcements - FDA approves first drug to treat tardive dyskinesia\"</a>. <i>www.fda.gov</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170412150022/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm552418.htm\">Archived</a> from the original on 12 April 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">12 April</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.fda.gov&amp;rft.atitle=Press+Announcements+-+FDA+approves+first+drug+to+treat+tardive+dyskinesia&amp;rft.aulast=Commissioner&amp;rft.aufirst=Office+of+the&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm552418.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209885Orig1s000TOC.cfm\">\"Drug Approval Package: Austedo (deutetrabenazine) Tablets\"</a>. <i>www.accessdata.fda.gov</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2018-09-14</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.accessdata.fda.gov&amp;rft.atitle=Drug+Approval+Package%3A+Austedo+%28deutetrabenazine%29+Tablets&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F2017%2F209885Orig1s000TOC.cfm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lerner, V; Miodownik, C; Kaptsan, A; Cohen, H; Matar, M; Loewenthal, U; Kotler, M (September 2001). <a rel=\"nofollow\" class=\"external text\" href=\"http://ajp.psychiatryonline.org/data/Journals/AJP/3728/1511.pdf\">\"Vitamin B6 in the Treatment of Tardive Dyskinesia: A Double-Blind, Placebo-Controlled, Crossover Study\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>The American Journal of Psychiatry</i>. <b>158</b> (9): 1511\u201314. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1176/appi.ajp.158.9.1511\">10.1176/appi.ajp.158.9.1511</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11532741\">11532741</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.atitle=Vitamin+B6+in+the+Treatment+of+Tardive+Dyskinesia%3A+A+Double-Blind%2C+Placebo-Controlled%2C+Crossover+Study&amp;rft.volume=158&amp;rft.issue=9&amp;rft.pages=1511-14&amp;rft.date=2001-09&amp;rft_id=info%3Adoi%2F10.1176%2Fappi.ajp.158.9.1511&amp;rft_id=info%3Apmid%2F11532741&amp;rft.au=Lerner%2C+V&amp;rft.au=Miodownik%2C+C&amp;rft.au=Kaptsan%2C+A&amp;rft.au=Cohen%2C+H&amp;rft.au=Matar%2C+M&amp;rft.au=Loewenthal%2C+U&amp;rft.au=Kotler%2C+M&amp;rft_id=http%3A%2F%2Fajp.psychiatryonline.org%2Fdata%2FJournals%2FAJP%2F3728%2F1511.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lerner, V; Miodownik, C; Kaptsan, A; Bersudsky, Y; Libov, I; Sela BA; Witztum, E (November 2007). \"Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study\". <i>Journal of Clinical Psychiatry</i>. <b>68</b> (11): 1648\u201354. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4088/jcp.v68n1103\">10.4088/jcp.v68n1103</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18052557\">18052557</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Psychiatry&amp;rft.atitle=Vitamin+B6+treatment+for+tardive+dyskinesia%3A+a+randomized%2C+double-blind%2C+placebo-controlled%2C+crossover+study&amp;rft.volume=68&amp;rft.issue=11&amp;rft.pages=1648-54&amp;rft.date=2007-11&amp;rft_id=info%3Adoi%2F10.4088%2Fjcp.v68n1103&amp;rft_id=info%3Apmid%2F18052557&amp;rft.au=Lerner%2C+V&amp;rft.au=Miodownik%2C+C&amp;rft.au=Kaptsan%2C+A&amp;rft.au=Bersudsky%2C+Y&amp;rft.au=Libov%2C+I&amp;rft.au=Sela+BA&amp;rft.au=Witztum%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Adelufosi_Cochrane-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Adelufosi_Cochrane_37-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Adelufosi, Adegoke Oloruntoba; Abayomi, Olukayode; Ojo, Tunde Massey-Ferguson (13 April 2015). \"Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia\". <i>Cochrane Database of Systematic Reviews</i>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD010501.pub2\">10.1002/14651858.CD010501.pub2</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Pyridoxal+5+phosphate+for+neuroleptic-induced+tardive+dyskinesia&amp;rft.date=2015-04-13&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD010501.pub2&amp;rft.aulast=Adelufosi&amp;rft.aufirst=Adegoke+Oloruntoba&amp;rft.au=Abayomi%2C+Olukayode&amp;rft.au=Ojo%2C+Tunde+Massey-Ferguson&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-TD2011-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-TD2011_38-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Aia, Pratibha G; Revuelta, Gonzalo J; Cloud, Leslie J; Factor, Stewart A (2011). \"Tardive Dyskinesia\". <i>Current Treatment Options in Neurology</i>. <b>13</b> (3): 231\u201341. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11940-011-0117-x\">10.1007/s11940-011-0117-x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21365202\">21365202</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Treatment+Options+in+Neurology&amp;rft.atitle=Tardive+Dyskinesia&amp;rft.volume=13&amp;rft.issue=3&amp;rft.pages=231-41&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1007%2Fs11940-011-0117-x&amp;rft_id=info%3Apmid%2F21365202&amp;rft.aulast=Aia&amp;rft.aufirst=Pratibha+G&amp;rft.au=Revuelta%2C+Gonzalo+J&amp;rft.au=Cloud%2C+Leslie+J&amp;rft.au=Factor%2C+Stewart+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bergman, H; Bhoopathi, PS; Soares-Weiser, K (20 January 2018). \"Benzodiazepines for antipsychotic-induced tardive dyskinesia\". <i>The Cochrane Database of Systematic Reviews</i>. <b>1</b>: CD000205. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD000205.pub3\">10.1002/14651858.CD000205.pub3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29352477\">29352477</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Benzodiazepines+for+antipsychotic-induced+tardive+dyskinesia.&amp;rft.volume=1&amp;rft.pages=CD000205&amp;rft.date=2018-01-20&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD000205.pub3&amp;rft_id=info%3Apmid%2F29352477&amp;rft.aulast=Bergman&amp;rft.aufirst=H&amp;rft.au=Bhoopathi%2C+PS&amp;rft.au=Soares-Weiser%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Alabed, S; Latifeh, Y; Mohammad, HA; Bergman, H (17 April 2018). \"Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia\". <i>The Cochrane Database of Systematic Reviews</i>. <b>4</b>: CD000203. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD000203.pub4\">10.1002/14651858.CD000203.pub4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29663328\">29663328</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Gamma-aminobutyric+acid+agonists+for+antipsychotic-induced+tardive+dyskinesia.&amp;rft.volume=4&amp;rft.pages=CD000203&amp;rft.date=2018-04-17&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD000203.pub4&amp;rft_id=info%3Apmid%2F29663328&amp;rft.aulast=Alabed&amp;rft.aufirst=S&amp;rft.au=Latifeh%2C+Y&amp;rft.au=Mohammad%2C+HA&amp;rft.au=Bergman%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Essali_et_al_Cochrane-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Essali_et_al_Cochrane_41-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Essali, Adib; Soares-Weiser, Karla; Bergman, Hanna; Adams, Clive E (26 March 2018). \"Calcium channel blockers for antipsychotic-induced tardive dyskinesia\". <i>Cochrane Database of Systematic Reviews</i>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD000206.pub4\">10.1002/14651858.CD000206.pub4</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Calcium+channel+blockers+for+antipsychotic-induced+tardive+dyskinesia&amp;rft.date=2018-03-26&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD000206.pub4&amp;rft.aulast=Essali&amp;rft.aufirst=Adib&amp;rft.au=Soares-Weiser%2C+Karla&amp;rft.au=Bergman%2C+Hanna&amp;rft.au=Adams%2C+Clive+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Llorca, Pierre-Michel; Chereau, Isabelle; Bayle, Frank-Jean;  et al. (2002). \"Tardive dyskinesias and antipsychotics: A review\". <i>European Psychiatry</i>. <b>17</b> (3): 129\u201338. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0924-9338%2802%2900647-8\">10.1016/S0924-9338(02)00647-8</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12052573\">12052573</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Psychiatry&amp;rft.atitle=Tardive+dyskinesias+and+antipsychotics%3A+A+review&amp;rft.volume=17&amp;rft.issue=3&amp;rft.pages=129-38&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1016%2FS0924-9338%2802%2900647-8&amp;rft_id=info%3Apmid%2F12052573&amp;rft.aulast=Llorca&amp;rft.aufirst=Pierre-Michel&amp;rft.au=Chereau%2C+Isabelle&amp;rft.au=Bayle%2C+Frank-Jean&amp;rft.au=Lancon%2C+Christophe&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Glenmullen, Joseph (2001). <i>Prozac Backlash: Overcoming the Dangers of Prozac, Zoloft, Paxil, and Other Antidepressants With Safe, Effective Alternatives</i>. New York: Simon &amp; Schuster. p.&#160;38. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-7432-0062-2\" title=\"Special:BookSources/978-0-7432-0062-2\">978-0-7432-0062-2</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Prozac+Backlash%3A+Overcoming+the+Dangers+of+Prozac%2C+Zoloft%2C+Paxil%2C+and+Other+Antidepressants+With+Safe%2C+Effective+Alternatives&amp;rft.place=New+York&amp;rft.pages=38&amp;rft.pub=Simon+%26+Schuster&amp;rft.date=2001&amp;rft.isbn=978-0-7432-0062-2&amp;rft.aulast=Glenmullen&amp;rft.aufirst=Joseph&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources_(medicine)\" title=\"Wikipedia:Identifying reliable sources (medicine)\"><span title=\"Material near this tag may rely on an unreliable or less reliable medical source. (June 2012)\">unreliable medical source?</span></a></i>&#93;</sup>&#160;::referring to <cite class=\"citation journal\">Glazer, William M.; Morgenstern, Hal; Doucette, John T. (1993). \"Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications\". <i>Journal of Clinical Psychiatry</i>. <b>54</b> (4): 133\u20139. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8098030\">8098030</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Psychiatry&amp;rft.atitle=Predicting+the+long-term+risk+of+tardive+dyskinesia+in+outpatients+maintained+on+neuroleptic+medications&amp;rft.volume=54&amp;rft.issue=4&amp;rft.pages=133-9&amp;rft.date=1993&amp;rft_id=info%3Apmid%2F8098030&amp;rft.aulast=Glazer&amp;rft.aufirst=William+M.&amp;rft.au=Morgenstern%2C+Hal&amp;rft.au=Doucette%2C+John+T.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jeste, Dilip V.; Caligiuri, Michael P.; Paulsen, Jane S.;  et al. (1995). \"Risk of Tardive Dyskinesia in Older Patients: A Prospective Longitudinal Study of 266 Outpatients\". <i>Archives of General Psychiatry</i>. <b>52</b> (9): 756\u201365. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/archpsyc.1995.03950210050010\">10.1001/archpsyc.1995.03950210050010</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7654127\">7654127</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+General+Psychiatry&amp;rft.atitle=Risk+of+Tardive+Dyskinesia+in+Older+Patients%3A+A+Prospective+Longitudinal+Study+of+266+Outpatients&amp;rft.volume=52&amp;rft.issue=9&amp;rft.pages=756-65&amp;rft.date=1995&amp;rft_id=info%3Adoi%2F10.1001%2Farchpsyc.1995.03950210050010&amp;rft_id=info%3Apmid%2F7654127&amp;rft.aulast=Jeste&amp;rft.aufirst=Dilip+V.&amp;rft.au=Caligiuri%2C+Michael+P.&amp;rft.au=Paulsen%2C+Jane+S.&amp;rft.au=Heaton%2C+Robert+K.&amp;rft.au=Lacro%2C+Jonathan+P.&amp;rft.au=Harris%2C+M.+Jackuelyn&amp;rft.au=Bailey%2C+Anne&amp;rft.au=Fell%2C+Robert+L.&amp;rft.au=McAdams%2C+Lou+Ann&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Whitaker, Robert (2002). <i>Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill</i>. Perseus.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Mad+in+America%3A+Bad+Science%2C+Bad+Medicine%2C+and+the+Enduring+Mistreatment+of+the+Mentally+Ill&amp;rft.pub=Perseus&amp;rft.date=2002&amp;rft.aulast=Whitaker&amp;rft.aufirst=Robert&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\"><span title=\"This citation requires a reference to the specific page or range of pages in which the material appears. (June 2012)\">page&#160;needed</span></a></i>&#93;</sup></span>\n</li>\n<li id=\"cite_note-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-46\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Marshall, DL; Hazlet, TK; Gardner, JS;  et al. (2002). \"Neuroleptic drug exposure and incidence of tardive dyskinesia: A records-based case-control study\". <i>Journal of managed care pharmacy</i>. <b>8</b> (4): 259\u201365. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14613418\">14613418</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+managed+care+pharmacy&amp;rft.atitle=Neuroleptic+drug+exposure+and+incidence+of+tardive+dyskinesia%3A+A+records-based+case-control+study&amp;rft.volume=8&amp;rft.issue=4&amp;rft.pages=259-65&amp;rft.date=2002&amp;rft_id=info%3Apmid%2F14613418&amp;rft.aulast=Marshall&amp;rft.aufirst=DL&amp;rft.au=Hazlet%2C+TK&amp;rft.au=Gardner%2C+JS&amp;rft.au=Blough%2C+DK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Tarsy, Daniel; Lungu, Codrin; Baldessarini, Ross J. (2011). \"Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs\".  In Vinken, P. J.; Bruyn, G. W. <i>Handbook of Clinical Neurology</i>. Hyperkinetic Movement Disorders. <b>100</b>. pp.&#160;601\u201316. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/B978-0-444-52014-2.00043-4\">10.1016/B978-0-444-52014-2.00043-4</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-444-52014-2\" title=\"Special:BookSources/978-0-444-52014-2\">978-0-444-52014-2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21496610\">21496610</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Epidemiology+of+tardive+dyskinesia+before+and+during+the+era+of+modern+antipsychotic+drugs&amp;rft.btitle=Handbook+of+Clinical+Neurology&amp;rft.series=Hyperkinetic+Movement+Disorders&amp;rft.pages=601-16&amp;rft.date=2011&amp;rft_id=info%3Apmid%2F21496610&amp;rft_id=info%3Adoi%2F10.1016%2FB978-0-444-52014-2.00043-4&amp;rft.isbn=978-0-444-52014-2&amp;rft.aulast=Tarsy&amp;rft.aufirst=Daniel&amp;rft.au=Lungu%2C+Codrin&amp;rft.au=Baldessarini%2C+Ross+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jeste, Dilip V.; Caligiuri, Michael P. (1993). <a rel=\"nofollow\" class=\"external text\" href=\"http://schizophreniabulletin.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=8100643\">\"Tardive Dyskinesia\"</a>. <i>Schizophrenia Bulletin</i>. <b>19</b> (2): 303\u201315. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/schbul/19.2.303\">10.1093/schbul/19.2.303</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8100643\">8100643</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Schizophrenia+Bulletin&amp;rft.atitle=Tardive+Dyskinesia&amp;rft.volume=19&amp;rft.issue=2&amp;rft.pages=303-15&amp;rft.date=1993&amp;rft_id=info%3Adoi%2F10.1093%2Fschbul%2F19.2.303&amp;rft_id=info%3Apmid%2F8100643&amp;rft.aulast=Jeste&amp;rft.aufirst=Dilip+V.&amp;rft.au=Caligiuri%2C+Michael+P.&amp;rft_id=http%3A%2F%2Fschizophreniabulletin.oxfordjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D8100643&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATardive+dyskinesia\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tardive_dyskinesia&amp;action=edit&amp;section=8\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"infobox\" style=\"width:22em;width:100%; margin:0 0 0.5em 0;\"><tbody><tr><th scope=\"row\">Classification</th><td style=\"text-align:left;\">\n<div style=\"position:relative; float:right; font-size:0.8em;\"><a href=\"https://www.wikidata.org/wiki/Q1546328\" class=\"extiw\" title=\"d:Q1546328\">D</a></div><div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems\" title=\"International Statistical Classification of Diseases and Related Health Problems\">ICD</a>-<a href=\"/wiki/ICD-10\" title=\"ICD-10\">10</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://apps.who.int/classifications/icd10/browse/2016/en#/G24.0\">G24.0</a></li><li><b><a href=\"/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems\" title=\"International Statistical Classification of Diseases and Related Health Problems\">ICD</a>-<a href=\"/wiki/List_of_ICD-9_codes\" title=\"List of ICD-9 codes\">9-CM</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.icd9data.com/getICD9Code.ashx?icd9=333.85\">333.85</a></li><li><b><a href=\"/wiki/OMIM\" class=\"mw-redirect\" title=\"OMIM\">OMIM</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"https://omim.org/entry/272620\">272620</a></li><li><b><a href=\"/wiki/Diseases_Database\" title=\"Diseases Database\">DiseasesDB</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.diseasesdatabase.com/ddb12909.htm\">12909</a></li></ul></div></td></tr><tr><th scope=\"row\">External resources</th><td style=\"text-align:left;\">\n<div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/MedlinePlus\" title=\"MedlinePlus\">MedlinePlus</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000685.htm\">000685</a></li><li><b><a href=\"/wiki/EMedicine\" title=\"EMedicine\">eMedicine</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.emedicine.com/neuro/topic362.htm\">neuro/362</a></li></ul></div></td></tr></tbody></table>\n\n<!-- \nNewPP limit report\nParsed by mw2242\nCached time: 20180921221627\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.596 seconds\nReal time usage: 0.677 seconds\nPreprocessor visited node count: 3710/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 121692/2097152 bytes\nTemplate argument size: 6581/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 3/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 72120/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.315/10.000 seconds\nLua memory usage: 6.68 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  590.791      1 -total\n 60.90%  359.806      1 Template:Reflist\n 24.90%  147.124     32 Template:Cite_journal\n 22.61%  133.563      2 Template:Infobox\n 21.36%  126.217      1 Template:Infobox_medical_condition_(new)\n 11.38%   67.249     10 Template:Cite_web\n  7.72%   45.587      5 Template:Fix\n  5.45%   32.224      1 Template:Medical_resources\n  4.98%   29.433      1 Template:IPAc-en\n  4.74%   28.026      1 Template:Distinguish\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:321556-0!canonical and timestamp 20180921221626 and revision id 859534941\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%AE%D9%84%D9%84_%D8%A7%D9%84%D8%AD%D8%B1%D9%83%D8%A9_%D8%A7%D9%84%D9%85%D8%AA%D8%A3%D8%AE%D8%B1","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u062e\u0644\u0644 \u0627\u0644\u062d\u0631\u0643\u0629 \u0627\u0644\u0645\u062a\u0623\u062e\u0631"},{"lang":"da","url":"https://da.wikipedia.org/wiki/Tardive_dyskinesier","langname":"Danish","autonym":"dansk","*":"Tardive dyskinesier"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Sp%C3%A4tdyskinesie","langname":"German","autonym":"Deutsch","*":"Sp\u00e4tdyskinesie"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Dyskin%C3%A9sie_tardive","langname":"French","autonym":"fran\u00e7ais","*":"Dyskin\u00e9sie tardive"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Discinesia_tardiva","langname":"Italian","autonym":"italiano","*":"Discinesia tardiva"},{"lang":"he","url":"https://he.wikipedia.org/wiki/%D7%93%D7%99%D7%A1%D7%A7%D7%99%D7%A0%D7%96%D7%99%D7%94_%D7%9E%D7%90%D7%95%D7%97%D7%A8%D7%AA","langname":"Hebrew","autonym":"\u05e2\u05d1\u05e8\u05d9\u05ea","*":"\u05d3\u05d9\u05e1\u05e7\u05d9\u05e0\u05d6\u05d9\u05d4 \u05de\u05d0\u05d5\u05d7\u05e8\u05ea"},{"lang":"nl","url":"https://nl.wikipedia.org/wiki/Tardieve_dyskinesie","langname":"Dutch","autonym":"Nederlands","*":"Tardieve dyskinesie"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E9%81%85%E7%99%BA%E6%80%A7%E3%82%B8%E3%82%B9%E3%82%AD%E3%83%8D%E3%82%B8%E3%82%A2","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u9045\u767a\u6027\u30b8\u30b9\u30ad\u30cd\u30b8\u30a2"},{"lang":"or","url":"https://or.wikipedia.org/wiki/%E0%AC%9F%E0%AC%BE%E0%AC%B0%E0%AD%8D%E0%AC%A1%E0%AC%BF%E0%AC%AD_%E0%AC%A1%E0%AC%BF%E0%AC%B8%E0%AC%95%E0%AC%BE%E0%AC%87%E0%AC%A8%E0%AD%87%E0%AC%B8%E0%AC%BF%E0%AC%86","langname":"Odia","autonym":"\u0b13\u0b21\u0b3c\u0b3f\u0b06","*":"\u0b1f\u0b3e\u0b30\u0b4d\u0b21\u0b3f\u0b2d \u0b21\u0b3f\u0b38\u0b15\u0b3e\u0b07\u0b28\u0b47\u0b38\u0b3f\u0b06"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Dyskineza_p%C3%B3%C5%BAna","langname":"Polish","autonym":"polski","*":"Dyskineza p\u00f3\u017ana"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Discinesia_tardia","langname":"Portuguese","autonym":"portugu\u00eas","*":"Discinesia tardia"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%9F%D0%BE%D0%B7%D0%B4%D0%BD%D1%8F%D1%8F_%D0%B4%D0%B8%D1%81%D0%BA%D0%B8%D0%BD%D0%B5%D0%B7%D0%B8%D1%8F","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u041f\u043e\u0437\u0434\u043d\u044f\u044f \u0434\u0438\u0441\u043a\u0438\u043d\u0435\u0437\u0438\u044f"},{"lang":"simple","url":"https://simple.wikipedia.org/wiki/Tardive_dyskinesia","langname":"Simple English","autonym":"Simple English","*":"Tardive dyskinesia"},{"lang":"sr","url":"https://sr.wikipedia.org/wiki/%D0%A2%D0%B0%D1%80%D0%B4%D0%B8%D0%B2%D0%BD%D0%B0_%D0%B4%D0%B8%D1%81%D0%BA%D0%B8%D0%BD%D0%B5%D0%B7%D0%B8%D1%98%D0%B0","langname":"Serbian","autonym":"\u0441\u0440\u043f\u0441\u043a\u0438 / srpski","*":"\u0422\u0430\u0440\u0434\u0438\u0432\u043d\u0430 \u0434\u0438\u0441\u043a\u0438\u043d\u0435\u0437\u0438\u0458\u0430"},{"lang":"sh","url":"https://sh.wikipedia.org/wiki/Tardivna_diskinezija","langname":"Serbo-Croatian","autonym":"srpskohrvatski / \u0441\u0440\u043f\u0441\u043a\u043e\u0445\u0440\u0432\u0430\u0442\u0441\u043a\u0438","*":"Tardivna diskinezija"},{"lang":"fi","url":"https://fi.wikipedia.org/wiki/Tardiivi_dyskinesia","langname":"Finnish","autonym":"suomi","*":"Tardiivi dyskinesia"},{"lang":"sv","url":"https://sv.wikipedia.org/wiki/Tardiv_dyskinesi","langname":"Swedish","autonym":"svenska","*":"Tardiv dyskinesi"},{"lang":"tr","url":"https://tr.wikipedia.org/wiki/Tardiv_diskinezi","langname":"Turkish","autonym":"T\u00fcrk\u00e7e","*":"Tardiv diskinezi"}],"categories":[{"sortkey":"","hidden":"","*":"Articles_with_incomplete_citations_from_March_2018"},{"sortkey":"","hidden":"","*":"All_articles_with_incomplete_citations"},{"sortkey":"","hidden":"","*":"All_articles_lacking_reliable_references"},{"sortkey":"","hidden":"","*":"Articles_lacking_reliable_references_from_June_2012"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_needing_page_number_citations_from_June_2012"},{"sortkey":"","hidden":"","*":"Infobox_medical_condition_(new)"},{"sortkey":"","*":"Neurological_disorders"},{"sortkey":"","*":"Symptoms_and_signs:_Nervous_system"},{"sortkey":"","*":"Syndromes"},{"sortkey":"","hidden":"","*":"RTT"},{"sortkey":"","hidden":"","*":"RTTNEURO"},{"sortkey":"","*":"Tardive_dyskinesia"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with incomplete citations from March 2018"},{"ns":14,"exists":"","*":"Category:Articles lacking reliable references from June 2012"},{"ns":14,"exists":"","*":"Category:Wikipedia articles needing page number citations from June 2012"},{"ns":0,"exists":"","*":"5-HT2A receptor"},{"ns":0,"exists":"","*":"5-HT2C receptor"},{"ns":0,"exists":"","*":"Akathisia"},{"ns":0,"exists":"","*":"Antiemetics"},{"ns":0,"exists":"","*":"Antioxidants"},{"ns":0,"exists":"","*":"Antipsychotic"},{"ns":0,"exists":"","*":"Antipsychotic drugs"},{"ns":0,"exists":"","*":"Aripiprazole"},{"ns":0,"exists":"","*":"Athetosis"},{"ns":0,"exists":"","*":"Atypical antipsychotic"},{"ns":0,"exists":"","*":"Baclofen"},{"ns":0,"exists":"","*":"Benzodiazepines"},{"ns":0,"exists":"","*":"Body dysmorphic disorder"},{"ns":0,"exists":"","*":"Botox"},{"ns":0,"exists":"","*":"Botulinum toxin"},{"ns":0,"exists":"","*":"Calcium channel blockers"},{"ns":0,"exists":"","*":"Cerebral palsy"},{"ns":0,"exists":"","*":"Chlorpromazine"},{"ns":0,"exists":"","*":"Chorea"},{"ns":0,"exists":"","*":"Clonidine"},{"ns":0,"exists":"","*":"Clozapine"},{"ns":0,"exists":"","*":"Deutetrabenazine"},{"ns":0,"exists":"","*":"Diagnostic method"},{"ns":0,"exists":"","*":"Differential diagnosis"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Diltiazem"},{"ns":0,"exists":"","*":"Diseases Database"},{"ns":0,"exists":"","*":"Dopamine"},{"ns":0,"exists":"","*":"Dopamine D3 receptor"},{"ns":0,"exists":"","*":"Dyskinetic cerebral palsy"},{"ns":0,"exists":"","*":"Dystonia"},{"ns":0,"exists":"","*":"EMedicine"},{"ns":0,"exists":"","*":"Electroconvulsive therapy"},{"ns":0,"exists":"","*":"Extrapyramidal system"},{"ns":0,"exists":"","*":"FDA"},{"ns":0,"exists":"","*":"Gastrointestinal disorder"},{"ns":0,"exists":"","*":"Huntington's disease"},{"ns":0,"exists":"","*":"ICD-10"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Statistical Classification of Diseases and Related Health Problems"},{"ns":0,"exists":"","*":"Isotopomers"},{"ns":0,"exists":"","*":"List of ICD-9 codes"},{"ns":0,"exists":"","*":"MedlinePlus"},{"ns":0,"exists":"","*":"Melatonin"},{"ns":0,"exists":"","*":"Mental illness"},{"ns":0,"exists":"","*":"Metoclopramide"},{"ns":0,"exists":"","*":"Myoclonus"},{"ns":0,"exists":"","*":"Neuroleptic"},{"ns":0,"exists":"","*":"Neuroleptic medication"},{"ns":0,"exists":"","*":"Neurological disorder"},{"ns":0,"exists":"","*":"Neurology"},{"ns":0,"exists":"","*":"Nigrostriatal pathway"},{"ns":0,"exists":"","*":"OMIM"},{"ns":0,"exists":"","*":"Parkinson's disease"},{"ns":0,"exists":"","*":"Polymorphism (biology)"},{"ns":0,"exists":"","*":"Progabide"},{"ns":0,"exists":"","*":"Promethazine"},{"ns":0,"exists":"","*":"Psychiatry"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Schizophrenia"},{"ns":0,"exists":"","*":"Sodium valproate"},{"ns":0,"exists":"","*":"Specialty (medicine)"},{"ns":0,"exists":"","*":"Tetrabenazine"},{"ns":0,"exists":"","*":"Tetrahydroisoxazolopyridinol"},{"ns":0,"exists":"","*":"Tic"},{"ns":0,"exists":"","*":"Tourette syndrome"},{"ns":0,"exists":"","*":"Tourettism"},{"ns":0,"exists":"","*":"Typical antipsychotic"},{"ns":0,"exists":"","*":"Valbenazine"},{"ns":0,"exists":"","*":"Vitamin B6"},{"ns":0,"exists":"","*":"Vitamin E"},{"ns":0,"exists":"","*":"Vitamins"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Identifying reliable sources (medicine)"},{"ns":12,"exists":"","*":"Help:IPA/English"}],"templates":[{"ns":10,"exists":"","*":"Template:Distinguish"},{"ns":10,"exists":"","*":"Template:Infobox medical condition (new)"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:IPAc-en"},{"ns":10,"exists":"","*":"Template:Ubl"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Full citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:MEDRS"},{"ns":10,"exists":"","*":"Template:Unreliable medical source"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Page needed"},{"ns":10,"exists":"","*":"Template:Medical resources"},{"ns":10,"exists":"","*":"Template:Hlist"},{"ns":10,"exists":"","*":"Template:ICD10"},{"ns":10,"exists":"","*":"Template:ICD9"},{"ns":10,"exists":"","*":"Template:Str find"},{"ns":828,"exists":"","*":"Module:Distinguish"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:IPAc-en"},{"ns":828,"exists":"","*":"Module:IPAc-en/data"},{"ns":828,"exists":"","*":"Module:IPAc-en/pronunciation"},{"ns":828,"exists":"","*":"Module:IPAc-en/phonemes"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:String2"},{"ns":828,"exists":"","*":"Module:WikidataIB/sandbox"},{"ns":828,"exists":"","*":"Module:Complex date"},{"ns":828,"exists":"","*":"Module:I18n/complex date"},{"ns":828,"exists":"","*":"Module:Ordinal"},{"ns":828,"exists":"","*":"Module:Roman"},{"ns":828,"exists":"","*":"Module:ISOdate"},{"ns":828,"exists":"","*":"Module:DateI18n"},{"ns":828,"exists":"","*":"Module:I18n/date"},{"ns":828,"exists":"","*":"Module:Calendar"},{"ns":828,"exists":"","*":"Module:I18n"},{"ns":828,"*":"Module:WikidataIB/i18n"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:String"}],"images":["Lock-green.svg","Dopamine-3d-CPK.png"],"externallinks":["https://rarediseases.info.nih.gov/diseases/7732/tardive-dyskinesia","https://web.archive.org/web/20170618062648/https://rarediseases.info.nih.gov/diseases/7732/tardive-dyskinesia","https://rarediseases.org/rare-diseases/tardive-dyskinesia/","https://web.archive.org/web/20170828234422/https://rarediseases.org/rare-diseases/tardive-dyskinesia/","//doi.org/10.1007/s40265-016-0568-1","//www.ncbi.nlm.nih.gov/pubmed/27091214","https://www.ninds.nih.gov/Disorders/All-Disorders/Tardive-Dyskinesia-Information-Page#disorders-r1","https://web.archive.org/web/20170704205427/https://www.ninds.nih.gov/Disorders/All-Disorders/Tardive-Dyskinesia-Information-Page#disorders-r1","//doi.org/10.4088/jcp.16r10832","//www.ncbi.nlm.nih.gov/pubmed/28146614","http://emedicine.medscape.com/article/1151826-overview#showall","https://web.archive.org/web/20131203011126/http://emedicine.medscape.com/article/1151826-overview#showall","http://www.ninds.nih.gov/disorders/tardive/tardive.htm","https://web.archive.org/web/20120427104252/http://www.ninds.nih.gov/disorders/tardive/tardive.htm","https://web.archive.org/web/20120421140945/http://www.nami.org/Content/ContentGroups/Helpline1/Tardive_Dyskinesia.htm","http://www.nami.org/Content/ContentGroups/Helpline1/Tardive_Dyskinesia.htm","http://www.dukehealth.org/services/neurological_disorders/care_guides/additional_movement_disorders/","https://web.archive.org/web/20120524065319/http://www.dukehealth.org/services/neurological_disorders/care_guides/additional_movement_disorders","//doi.org/10.1111/j.1600-0447.1986.tb02717.x","//www.ncbi.nlm.nih.gov/pubmed/2875609","//doi.org/10.1016/S0033-3182(85)72863-0","//www.ncbi.nlm.nih.gov/pubmed/2859630","//doi.org/10.1192/bjp.bp.108.049395","//www.ncbi.nlm.nih.gov/pubmed/19336789","//www.ncbi.nlm.nih.gov/pubmed/2905654","http://www.priory.com/tardive-dyskinesia.htm","https://web.archive.org/web/20080118011913/http://www.priory.com/tardive-dyskinesia.htm","https://books.google.com/books?id=SomdZ-8jnVgC&pg=PA101","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3825689","//doi.org/10.2147/DDDT.S32328","//www.ncbi.nlm.nih.gov/pubmed/24235816","//doi.org/10.1177/0269881108089591","//www.ncbi.nlm.nih.gov/pubmed/18515468","//doi.org/10.1177/0004867412461058","//www.ncbi.nlm.nih.gov/pubmed/22990431","//doi.org/10.1176/ajp.130.9.1043-a","//www.ncbi.nlm.nih.gov/pubmed/4727768","//doi.org/10.1176/ajp.130.10.1159","//www.ncbi.nlm.nih.gov/pubmed/4728916","//doi.org/10.1016/0006-3223(87)90131-4","//www.ncbi.nlm.nih.gov/pubmed/3790642","//www.ncbi.nlm.nih.gov/pmc/articles/PMC161742","//www.ncbi.nlm.nih.gov/pubmed/12790158","//doi.org/10.1016/j.pnpbp.2011.06.006","//www.ncbi.nlm.nih.gov/pubmed/21723906","//doi.org/10.1016/j.eurpsy.2008.07.007","//www.ncbi.nlm.nih.gov/pubmed/18774276","//doi.org/10.1007/s002130000521","//www.ncbi.nlm.nih.gov/pubmed/11140333","//doi.org/10.1176/appi.neuropsych.19.4.484-a","//www.ncbi.nlm.nih.gov/pubmed/18070868","//doi.org/10.1097/01.nrl.0000038585.58012.97","//www.ncbi.nlm.nih.gov/pubmed/12801428","//www.ncbi.nlm.nih.gov/pmc/articles/PMC487007","//www.ncbi.nlm.nih.gov/pubmed/16001096","https://books.google.com/books?id=SJLrIa7yFBgC&pg=PA109","//doi.org/10.1007/978-94-007-0834-1_6","//doi.org/10.1002/14651858.CD000209.pub3","//www.ncbi.nlm.nih.gov/pubmed/29341067","https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm552418.htm","https://web.archive.org/web/20170412150022/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm552418.htm","https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209885Orig1s000TOC.cfm","http://ajp.psychiatryonline.org/data/Journals/AJP/3728/1511.pdf","//doi.org/10.1176/appi.ajp.158.9.1511","//www.ncbi.nlm.nih.gov/pubmed/11532741","//doi.org/10.4088/jcp.v68n1103","//www.ncbi.nlm.nih.gov/pubmed/18052557","//doi.org/10.1002/14651858.CD010501.pub2","//doi.org/10.1007/s11940-011-0117-x","//www.ncbi.nlm.nih.gov/pubmed/21365202","//doi.org/10.1002/14651858.CD000205.pub3","//www.ncbi.nlm.nih.gov/pubmed/29352477","//doi.org/10.1002/14651858.CD000203.pub4","//www.ncbi.nlm.nih.gov/pubmed/29663328","//doi.org/10.1002/14651858.CD000206.pub4","//doi.org/10.1016/S0924-9338(02)00647-8","//www.ncbi.nlm.nih.gov/pubmed/12052573","//www.ncbi.nlm.nih.gov/pubmed/8098030","//doi.org/10.1001/archpsyc.1995.03950210050010","//www.ncbi.nlm.nih.gov/pubmed/7654127","//www.ncbi.nlm.nih.gov/pubmed/14613418","//doi.org/10.1016/B978-0-444-52014-2.00043-4","//www.ncbi.nlm.nih.gov/pubmed/21496610","http://schizophreniabulletin.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=8100643","//doi.org/10.1093/schbul/19.2.303","//www.ncbi.nlm.nih.gov/pubmed/8100643","http://apps.who.int/classifications/icd10/browse/2016/en#/G24.0","http://www.icd9data.com/getICD9Code.ashx?icd9=333.85","https://omim.org/entry/272620","http://www.diseasesdatabase.com/ddb12909.htm","https://www.nlm.nih.gov/medlineplus/ency/article/000685.htm","http://www.emedicine.com/neuro/topic362.htm"],"sections":[{"toclevel":1,"level":"2","line":"Signs and symptoms","number":"1","index":"1","fromtitle":"Tardive_dyskinesia","byteoffset":5069,"anchor":"Signs_and_symptoms"},{"toclevel":1,"level":"2","line":"Causes","number":"2","index":"2","fromtitle":"Tardive_dyskinesia","byteoffset":10523,"anchor":"Causes"},{"toclevel":2,"level":"3","line":"Risk factors","number":"2.1","index":"3","fromtitle":"Tardive_dyskinesia","byteoffset":15644,"anchor":"Risk_factors"},{"toclevel":1,"level":"2","line":"Prevention","number":"3","index":"4","fromtitle":"Tardive_dyskinesia","byteoffset":19055,"anchor":"Prevention"},{"toclevel":1,"level":"2","line":"Treatment","number":"4","index":"5","fromtitle":"Tardive_dyskinesia","byteoffset":22076,"anchor":"Treatment"},{"toclevel":1,"level":"2","line":"Epidemiology","number":"5","index":"6","fromtitle":"Tardive_dyskinesia","byteoffset":26456,"anchor":"Epidemiology"},{"toclevel":1,"level":"2","line":"References","number":"6","index":"7","fromtitle":"Tardive_dyskinesia","byteoffset":32178,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"7","index":"8","fromtitle":"Tardive_dyskinesia","byteoffset":32206,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Tardive dyskinesia","iwlinks":[{"prefix":"d","url":"https://www.wikidata.org/wiki/Q1546328","*":"d:Q1546328"}],"properties":[{"name":"wikibase_item","*":"Q1546328"}]}}